Your browser doesn't support javascript.
loading
A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.
Brett, Jamie O; Dubash, Taronish D; Johnson, Gabriela N; Niemierko, Andrzej; Mariotti, Veronica; Kim, Leslie S L; Xi, Jing; Pandey, Apurva; Dunne, Siobhan; Nasrazadani, Azadeh; Lloyd, Maxwell R; Kambadakone, Avinash; Spring, Laura M; Micalizzi, Douglas S; Onozato, Maristela L; Che, Dante; Nayar, Utthara; Brufsky, Adam; Kalinsky, Kevin; Ma, Cynthia X; O'Shaughnessy, Joyce; Han, Hyo S; Iafrate, Anthony J; Ryan, Lianne Y; Juric, Dejan; Moy, Beverly; Ellisen, Leif W; Maheswaran, Shyamala; Wagle, Nikhil; Haber, Daniel A; Bardia, Aditya; Wander, Seth A.
  • Brett JO; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Dubash TD; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Johnson GN; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Niemierko A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Mariotti V; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Kim LSL; Moffitt Cancer Center, Tampa, FL.
  • Xi J; Bristol Myers Squibb, New York, NY.
  • Pandey A; Baylor University Medical Center Charles A. Sammons Cancer Center, Texas Oncology, Dallas, TX.
  • Dunne S; Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Nasrazadani A; Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Lloyd MR; Baylor University Medical Center Charles A. Sammons Cancer Center, Texas Oncology, Dallas, TX.
  • Kambadakone A; Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Spring LM; Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX.
  • Micalizzi DS; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Onozato ML; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
  • Che D; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Nayar U; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Brufsky A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Kalinsky K; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Ma CX; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • O'Shaughnessy J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Han HS; Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Iafrate AJ; Department of Medicine, Columbia University Irving Medical Center, New York, NY.
  • Ryan LY; Emory University Winship Cancer Institute, Atlanta, GA.
  • Juric D; Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Moy B; Baylor University Medical Center Charles A. Sammons Cancer Center, Texas Oncology, Dallas, TX.
  • Ellisen LW; Moffitt Cancer Center, Tampa, FL.
  • Maheswaran S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Wagle N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Haber DA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Wander SA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
JCO Precis Oncol ; 7: e2200532, 2023 05.
Article en En | MEDLINE | ID: mdl-37141550

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article